ZA200007770B - Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments. - Google Patents

Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments. Download PDF

Info

Publication number
ZA200007770B
ZA200007770B ZA200007770A ZA200007770A ZA200007770B ZA 200007770 B ZA200007770 B ZA 200007770B ZA 200007770 A ZA200007770 A ZA 200007770A ZA 200007770 A ZA200007770 A ZA 200007770A ZA 200007770 B ZA200007770 B ZA 200007770B
Authority
ZA
South Africa
Prior art keywords
general formula
denote
methyl
nitrogen
denote hydrogen
Prior art date
Application number
ZA200007770A
Other languages
English (en)
Inventor
Matthias Grauert
Christoph Hoenke
Adrian Carter
Wolf-Dietrich Bechtel
Thomas Weiser
Rainer Palluk
Uwe Pschorn
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ZA200007770B publication Critical patent/ZA200007770B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200007770A 1998-07-31 2000-12-21 Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments. ZA200007770B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19834714A DE19834714A1 (de) 1998-07-31 1998-07-31 Neue 2,3,3a,4,9,9a-Hexahydro-8-hydroxy-1H-ben[f]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ZA200007770B true ZA200007770B (en) 2002-01-17

Family

ID=7876092

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200007770A ZA200007770B (en) 1998-07-31 2000-12-21 Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments.

Country Status (30)

Country Link
US (1) US6051583A (ru)
EP (1) EP1100780B1 (ru)
JP (1) JP2002522418A (ru)
KR (1) KR20010072142A (ru)
CN (1) CN1147470C (ru)
AT (1) ATE360611T1 (ru)
AU (1) AU763834B2 (ru)
BG (1) BG105178A (ru)
BR (1) BR9912605A (ru)
CA (1) CA2336783C (ru)
CO (1) CO5080748A1 (ru)
DE (2) DE19834714A1 (ru)
EA (1) EA003370B1 (ru)
EE (1) EE200100062A (ru)
ES (1) ES2285851T3 (ru)
HK (1) HK1038017A1 (ru)
HU (1) HUP0103518A3 (ru)
ID (1) ID28292A (ru)
IL (1) IL140863A0 (ru)
MY (1) MY133085A (ru)
NO (1) NO20010513D0 (ru)
NZ (1) NZ510246A (ru)
PL (1) PL345808A1 (ru)
SK (1) SK1502001A3 (ru)
TR (1) TR200100316T2 (ru)
TW (1) TW464643B (ru)
UA (1) UA68388C2 (ru)
WO (1) WO2000007986A1 (ru)
YU (1) YU5501A (ru)
ZA (1) ZA200007770B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002666D0 (en) 2000-02-04 2000-03-29 Univ London Blockade of voltage dependent sodium channels
DE60219687T2 (de) * 2001-12-27 2007-12-27 Ortho-Mcneil Pharmaceutical, Inc. Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69030665T2 (de) * 1989-07-13 1997-10-02 Pharmacia & Upjohn Co., Kalamazoo, Mich. (1,2n) und (3,2n)-karbozyklische-2-amino-tetralinderivate
WO1992021654A2 (en) * 1991-05-20 1992-12-10 The Upjohn Company Carboxamido-(3,2n)-carbocyclic-2-aminotetralin derivatives
GB9612153D0 (en) * 1996-06-11 1996-08-14 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
MY133085A (en) 2007-10-31
CO5080748A1 (es) 2001-09-25
CA2336783C (en) 2009-04-28
TR200100316T2 (tr) 2001-07-23
NZ510246A (en) 2003-08-29
CN1147470C (zh) 2004-04-28
EP1100780A1 (de) 2001-05-23
HUP0103518A2 (hu) 2002-01-28
AU5162699A (en) 2000-02-28
HK1038017A1 (en) 2002-03-01
KR20010072142A (ko) 2001-07-31
DE59914314D1 (de) 2007-06-06
ID28292A (id) 2001-05-10
NO20010513L (no) 2001-01-30
WO2000007986A1 (de) 2000-02-17
NO20010513D0 (no) 2001-01-30
IL140863A0 (en) 2002-02-10
US6051583A (en) 2000-04-18
AU763834B2 (en) 2003-07-31
EE200100062A (et) 2002-06-17
TW464643B (en) 2001-11-21
EA003370B1 (ru) 2003-04-24
JP2002522418A (ja) 2002-07-23
YU5501A (sh) 2003-04-30
PL345808A1 (en) 2002-01-02
ES2285851T3 (es) 2007-11-16
ATE360611T1 (de) 2007-05-15
EP1100780B1 (de) 2007-04-25
DE19834714A1 (de) 2000-02-03
CN1310707A (zh) 2001-08-29
SK1502001A3 (en) 2001-09-11
CA2336783A1 (en) 2000-02-17
BR9912605A (pt) 2001-05-02
EA200100107A1 (ru) 2001-08-27
BG105178A (en) 2001-12-29
UA68388C2 (en) 2004-08-16
HUP0103518A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
EP2486002B1 (en) Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
US7833997B2 (en) Analogs of benzoquinone-containing ansamycins and methods of use thereof
US8299053B2 (en) Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
JPH01203400A (ja) アデノシン誘導体
DE602004011051T2 (de) Verfahren zur behandlung von krankheiten mit hsp90-hemmenden mitteln in kombination mit antimetaboliten
WO1994015607A1 (fr) Application de la lamotrigine dans le traitement de la maladie de parkinson et des syndromes parkinsoniens
JPS5976086A (ja) プテリジン化合物
JP6321274B2 (ja) トリプル再取込み阻害剤及びそれらの使用方法
RU2468015C2 (ru) Полиморфные формы деферасирокса (icl670a)
EP0161599A2 (de) Neue Benzazepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
ZA200007770B (en) Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments.
EP3353163B1 (en) 2,3,4,5-tetrahydropyridin-6-amine derivatives
WO2020232332A1 (en) Pyrrolopyrimidine inhibitors of wild-type and mutant forms of lrrk2
WO2018107131A1 (en) Methylphenidate-prodrugs, processes of making and using the same
US20030027827A1 (en) Pharmaceutically active morpholinol
US4221788A (en) 2-(Optionally-substituted)benzylperhydroazepines for analgesia and lowering blood pressure
EP0681474B1 (en) Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders
EP1887004A1 (en) Crystalline forms of (1R,2R)-7-Chloro-3-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]quinazolin-4(3H)-one
WO1997048680A1 (fr) Sel de methanesulfonate d'une arylpiperazine derivee de tryptamine et ses solvates pour usage pharmaceutique
FR2711527A1 (fr) Utilisation de l'acriflavine comme agent anti HIV.
CZ2001399A3 (cs) Nové 2,3,3a,4,9,9a -hexahydro-8-hydroxy-lHbenz(f)indoly, způsob jejich výroby a použití jako léčiva
DE1911869A1 (de) 5,7-Dimethoxytryptaminverbindungen und deren Verwendung als Pharmazeutica
BE632520A (ru)
FR2700115A1 (fr) Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2700114A1 (fr) Application de la lamotrigine dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.